Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cipher Pharmaceuticals Inc T.DND

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with three commercial products and a fourth in development. The Company is engaged in clinical and regulatory affairs, product licensing, supply chain management, and marketing and sales.
Price: $15.53 | Change: +$0.07 | %Change: +0.45%
Volume: 74,749 | Day High/Low: 15.90/15.40 | 52 Week High/Low: 16.28/6.75
View modes: 
0 stars

The average PE on the Nazdaq is much higher than on the TSX

Just look at the price per share earnings multiples of the average company on the NAZDAQ compared to Cipher, to see if Cipher can do better on the NAZDAQ. KISU is a Biosyent pumper their PE is around...read more
3 stars

RE:RE:RE:RE:Nazdaq listing at same time as Ranbaxy Absorbica sales push

What makes you think the TSX is holding it back???  Not much excitment about the Nasdaq listing today so far.  rate and reply
0 stars

RE:RE:RE:Nazdaq listing at same time as Ranbaxy Absorbica sales push

thanks.....so we're on both exchanges....do you think the tsx listing will hold it back still?  rate and reply
0 stars

RE:RE:Nazdaq listing at same time as Ranbaxy Absorbica sales push

On average I would say at least $25.00 to $30.00 per share for a comperable American company.  These are American companies trading at 30 to 40 times earnings of which there are very very many. Look...read more
0 stars

RE:Nazdaq listing at same time as Ranbaxy Absorbica sales push

If DND were to trade at the same level as it's peers on the nasdaq what share price are we looking at?  rate and reply
0 stars

Cipher $16.20 one day, $15 the next, $16 the third day

This is a very normal fluctuation for any stock. It can't go straight up.  rate and reply
0 stars

Nazdaq listing at same time as Ranbaxy Absorbica sales push

There is good chance this new listing will coincide with good news for Absorbica sales in the USA with the new dosages and a big sales push by Ranbaxy. We may see $20.00 or higher with this new double...read more
0 stars

RE:nasdaq listing

That is definitely great news. Funny, we were speculating on how long the it would take, just yesterday.  rate and reply
0 stars

nasdaq listing

Cipher Pharmaceuticals to commence trading on the NASDAQ Global Market 14 minutes ago...read more
3 stars

RE:Wow! Down 4.4%!!

Cipher Pharmaceuticals Inc closed sharply lower Wednesday, dropping $0.71 or 4.44% to $15.28. Over the last five days, shares have gained 1.06% and 97.42% year to date. Shares have outperformed the S...read more
3 stars

RE:Wow! Down 4.4%!!

since your week ago implosion it ia up 1.87% this month 37% never predict, especially when you are wrong.  rate and reply
0 stars

RE:RE:Ugh, another pullback from $16

Dunno. It was announced in their Q3 CC on Oct 29 (http://www.cipherpharma.com/Investor-Relations/News/news-details/2014/Cipher-Reports-Financial-Results-for-Q3-2014/default.aspx). Apparently they...read more
1 star

Wow! Down 4.4%!!

The year 2013 buy-ins are heading for the exit door, the "easy money" has been made.  rate and reply
0 stars

RE:Ugh, another pullback from $16

Is there actual talk of a nasdaq listing? ....or is that just wishful thinking.  rate and reply
0 stars

Ugh, another pullback from $16

Hopefully we hear back all about the NASDAQ listing. That should give the sp a nice, probably more permant boost.  rate and reply
3.5 stars

biotech/pharma hot

take care.... cheers, dave.  rate and reply
3 stars

RE:RE:RE:How about an apology to me Wittman?

How about taking your perpetual and irrelevant dialogue to your inbox. We are neither amused nor interested.  rate and reply
5 stars

RE:RE:How about an apology to me Wittman?

wittman will never apolagize check out his posts on stp and bkx. He calls everybody names and how childish they are . Check it out and spread the word. He is nothing but a mean spirited child that...read more
3.5 stars

RE:Ha, ha, ha

uchuck, you are confusing different types of investors. Some of us have had this stock since day one. There are those who put all their chips on one stock hoping for the super huge payoff (could...read more
3 stars

By Qtr 3 2015 Absorbica#1 Acutane acne drug in USA

I predict Absorbica is going to have a big 4th quarter in the USA market now that Ranbaxy under new and better management have decided to spend some money on Absorbica (new dosages more sales reps etc...read more

Private Equity


Own a piece of our private equity marketplace: Limited to 50 members.

Click here to watch video 4

How to invest in private equity without writing a $1 million check.

Click here to watch video 3

Why the wealthy are 23x wealthier than the average investor.

Click here to watch video 2

Private Equity: Find out why it returned 16% p.a. for 10 years.


Click here to watch video 1